Not a good buy right now at 31.91 pre-market: the stock is technically overextended (RSI ~82) and already trading above first resistance (R1 31.756), leaving limited near-term upside vs. resistance at 32.496.
Wall Street stance is effectively neutral (Market Perform) with a $32 target, implying minimal upside from current price.
Financial momentum is strong (2025/Q4 EPS and net income roughly doubled YoY), but with no fresh news catalysts and an overbought tape, the risk/reward for an impatient entry is unattractive.
Best setup would be on a pullback toward ~30.56 (pivot) or ~29.36 (S1); at current levels, avoid chasing.
Technical Analysis
Trend/Momentum: MACD histogram is positive and expanding (bullish momentum), but RSI_6 at 81.889 signals an overbought/late-stage move where pullbacks are common.
Moving averages: Converging MAs suggests the trend is not strongly trending long-term; price strength looks more like a recent push than a clean sustained breakout.
Pattern-based forward odds: Similar-pattern stats show a 40% chance of -0.87% next day and -0.15% next week, with a modest +1.45% one-month bias—consistent with near-term digestion after a run.
Positioning (OI): Put/Call OI ratio at 0.15 is call-heavy (bullish positioning), but total open interest is small (calls 46 vs puts 7), suggesting limited signaling power.
Activity: Options volume is effectively zero today, so there’s no strong real-time sentiment confirmation.
Volatility: 30D IV 136% with high IV percentile (83.6) indicates expensive options / elevated implied move expectations, often seen in less liquid names or around uncertainty—another reason not to chase at an overbought spot price.
Technical Summary
Sell
5
Buy
11
Positive Catalysts
Strong latest-quarter fundamentals (2025/Q4): revenue +6.72% YoY; net income +99.62% YoY; EPS +102.22% YoY.
Bullish options positioning by open interest (call-heavy) can support dips if sentiment holds.
No negative news flow in the past week (no fresh headline overhang).
Neutral/Negative Catalysts
increases near-term pullback risk, especially after pushing above R
Limited upside vs. Street view: price is already near the latest $32 target, capping immediate rerating potential.
Financial Performance
2025/Q4: Revenue 54.09M, up 6.72% YoY (steady top-line growth).
2025/Q4: Net income 15.04M, up 99.62% YoY (major profitability acceleration).
2025/Q4: EPS 0.91, up 102.22% YoY (strong earnings momentum).
Takeaway: Fundamentals are improving sharply, but the current entry point looks technically stretched.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Latest (2026-02-02): Keefe Bruyette raised PT to $32 (from $31) and maintained Market Perform—incrementally more positive but still not a “buy” call.
Prior (2025-11-10): Keefe Bruyette cut PT to $31 (from $33) while keeping Market Perform—overall stance has stayed neutral with only minor PT tweaks.
Wall Street pros: improving earnings trend and presumably solid banking fundamentals.
Wall Street cons: valuation/upside appears tighter now; neutral rating suggests limited conviction for outsized near-term returns.
Influential trading: No recent congress trading data available; hedge fund and insider trading trends are neutral (no strong conviction signal).
Wall Street analysts forecast CBNK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CBNK is 34 USD with a low forecast of 31 USD and a high forecast of 37 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast CBNK stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CBNK is 34 USD with a low forecast of 31 USD and a high forecast of 37 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Buy
1 Hold
0 Sell
Moderate Buy
Current: 32.010
Low
31
Averages
34
High
37
Current: 32.010
Low
31
Averages
34
High
37
Keefe Bruyette
Market Perform
maintain
$31 -> $32
AI Analysis
2026-02-02
Reason
Keefe Bruyette
Price Target
$31 -> $32
AI Analysis
2026-02-02
maintain
Market Perform
Reason
Keefe Bruyette raised the firm's price target on Capital Bancorp to $32 from $31 and keeps a Market Perform rating on the shares.
Raymond James
Strong Buy -> Market Perform
downgrade
2026-01-07
Reason
Raymond James
Price Target
2026-01-07
downgrade
Strong Buy -> Market Perform
Reason
Raymond James downgraded Chain Bridge Bancorp to Market Perform from Strong Buy without a price target. The downgrade reflects a narrower valuation gap to small cap peers and the risk of greater interest rate cuts from the Federal Reserve, which would pressure EPS estimates, the analyst tells investors in a research note. The firm likes the Chain Bridge franchise for its core deposit base, strong balance sheet liquidity and capital appreciation.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for CBNK
